Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Guilford receives government contract for cocaine addiction research

Aug. 11, 1997

Algos and NIDA enter into collaboration for heroin addiction treatment

Aug. 7, 1997

Nicotine Inhaler launched in The Netherlands

July 24, 1997

Novartis prepares orally active iron chelators

July 23, 1997

Dose-response trial of LAAM in opioid-dependent subjects

July 17, 1997

Smoking cessation treatment launched in the U.S.

July 10, 1997

Tolerance to benzodiazepine hypnotics overcome with melatonin

June 6, 1997

DynaGen licenses smoking cessation technology

June 6, 1997

FDA clears Glaxo Wellcome's aid to smoking cessation

May 16, 1997

ImmuLogic receives funds from NIH to develop cocaine vaccine

May 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...